Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents

Detalles Bibliográficos
Autor principal: Wang, Guangdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508469/
https://www.ncbi.nlm.nih.gov/pubmed/32968620
http://dx.doi.org/10.21037/tcr-20-2166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508469/
https://www.ncbi.nlm.nih.gov/pubmed/32968620
http://dx.doi.org/10.21037/tcr-20-2166

Ejemplares similares